RetromanIE
09-09-2011, 12:58
http://nt2.ggpht.com/news/tbn/YhwEqAJP__CbiM/0.jpg
InPharm (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGXrBnph-wfW0Mo5l1RjyeleYUFug&url=http://www.inpharm.com/news/166722/novartis-votubia-everolimus-european-sega-approval)
<img alt="" height="1" width="1" />
Everolimus approved to treat rare tumour disease (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGXrBnph-wfW0Mo5l1RjyeleYUFug&url=http://www.inpharm.com/news/166722/novartis-votubia-everolimus-european-sega-approval)
InPharm
Everolimus is already marketed as Afinitor in cancer and as Certican for organ rejection, and will now be known as Votubia to treat subependymal giant cell astrocytoma (SEGA). These non-cancerous brain tumours arise because of an underlying condition, ...
Novartis receives EU approval for Votubia®, the first medication to treat ... (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGGEnRr2FnoqugcgpuuGmJIYyhD7Q&url=http://www.reuters.com/article/2011/09/08/idUS48714%2B08-Sep-2011%2BHUG20110908)Reuters (press release)
EU approval for Janssen-Cilag's Zytiga in prostate cancer and Novartis ... (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE8UGkW4UH-F0CXUgaPwHUwCFb-Ow&url=http://www.thepharmaletter.com/file/107169/eu-approval-for-janssen-cilags-zytiga-in-prostate-cancer-and-novartis-votubia-for-sega.html)The Pharma Letter
Novartis Receives EU Approval For Brain Tumor Drug Votubia - Update (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEhk8pObOLWVoxr3n3ngiUeZ2c8DQ&url=http://www.rttnews.com/Content/BreakingNews.aspx?Id%3D1709130%26SM%3D1)RTT News
MarketWatch (press release) (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHMxYvuBwcYf60m232TgkBy_kqkiQ&url=http://www.marketwatch.com/story/novartis-receives-eu-approval-for-votubia-the-first-medication-to-treat-children-and-adults-with-sega-associated-with-tsc-2011-09-08)
all 21 news articles » (http://news.google.ie/news/more?pz=1&ned=en_ie&ncl=d0515SIzvjEKq-Mnr2alF2FCQ1QIM)
More... (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGXrBnph-wfW0Mo5l1RjyeleYUFug&url=http://www.inpharm.com/news/166722/novartis-votubia-everolimus-european-sega-approval)
InPharm (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGXrBnph-wfW0Mo5l1RjyeleYUFug&url=http://www.inpharm.com/news/166722/novartis-votubia-everolimus-european-sega-approval)
<img alt="" height="1" width="1" />
Everolimus approved to treat rare tumour disease (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGXrBnph-wfW0Mo5l1RjyeleYUFug&url=http://www.inpharm.com/news/166722/novartis-votubia-everolimus-european-sega-approval)
InPharm
Everolimus is already marketed as Afinitor in cancer and as Certican for organ rejection, and will now be known as Votubia to treat subependymal giant cell astrocytoma (SEGA). These non-cancerous brain tumours arise because of an underlying condition, ...
Novartis receives EU approval for Votubia®, the first medication to treat ... (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGGEnRr2FnoqugcgpuuGmJIYyhD7Q&url=http://www.reuters.com/article/2011/09/08/idUS48714%2B08-Sep-2011%2BHUG20110908)Reuters (press release)
EU approval for Janssen-Cilag's Zytiga in prostate cancer and Novartis ... (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE8UGkW4UH-F0CXUgaPwHUwCFb-Ow&url=http://www.thepharmaletter.com/file/107169/eu-approval-for-janssen-cilags-zytiga-in-prostate-cancer-and-novartis-votubia-for-sega.html)The Pharma Letter
Novartis Receives EU Approval For Brain Tumor Drug Votubia - Update (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEhk8pObOLWVoxr3n3ngiUeZ2c8DQ&url=http://www.rttnews.com/Content/BreakingNews.aspx?Id%3D1709130%26SM%3D1)RTT News
MarketWatch (press release) (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHMxYvuBwcYf60m232TgkBy_kqkiQ&url=http://www.marketwatch.com/story/novartis-receives-eu-approval-for-votubia-the-first-medication-to-treat-children-and-adults-with-sega-associated-with-tsc-2011-09-08)
all 21 news articles » (http://news.google.ie/news/more?pz=1&ned=en_ie&ncl=d0515SIzvjEKq-Mnr2alF2FCQ1QIM)
More... (http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGXrBnph-wfW0Mo5l1RjyeleYUFug&url=http://www.inpharm.com/news/166722/novartis-votubia-everolimus-european-sega-approval)